This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Baxter International (BAX) Receives a Hold from Stifel Nicolaus

Tipranks - Tipranks - Mon May 4, 9:16PM CDT

In a report released on May 1, Rick Wise from Stifel Nicolaus maintained a Hold rating on Baxter International, with a price target of $19.00. The company’s shares closed last Friday at $17.21.

Claim 55% Off TipRanks

Wise covers the Healthcare sector, focusing on stocks such as Boston Scientific, GE Healthcare Technologies Inc, and Zimmer Biomet Holdings. According to TipRanks, Wise has an average return of -2.2% and a 43.80% success rate on recommended stocks.

Baxter International has an analyst consensus of Hold, with a price target consensus of $20.18, representing a 17.26% upside. In a report released on May 1, Goldman Sachs also maintained a Hold rating on the stock with a $17.00 price target.

See today’s best-performing stocks on TipRanks >>

Based on Baxter International’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $2.7 billion and a GAAP net loss of $15 million. In comparison, last year the company earned a revenue of $2.63 billion and had a net profit of $126 million

Read More on BAX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).